Dexamethasone modifies the susceptibility to serum cytotoxicity and increases the metastatic efficiency of a colon carcinoma cell line

Experimental and Molecular Pathology

Volumn 81, Issue 1, 2006, Pages 77-84

  Yoshida, Yukio ^a   Kishimoto, Takashi ^a   Ishiguro, Hiroshi ^a   Nagai, Yuichiro ^a   Koda, Keiji ^a   Takiguchi, Nobuhiro ^a   Miyazaki, Masaru ^a   Ishikura, Hiroshi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon cancer; Dexamethasone; Hematogeneous metastasis; Metastatic inefficiency; Serum cytotoxicity

Indexed keywords

BETA GLOBIN; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; DEXAMETHASONE; MATRIX METALLOPROTEINASE; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN HT29; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; LIVER METASTASIS; LIVER WEIGHT; MALE; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; SERUM; STATISTICAL SIGNIFICANCE;

ANIMALS; CARCINOMA; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DEXAMETHASONE; GLOBINS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; ORGAN SIZE; RNA, MESSENGER; TOXINS, BIOLOGICAL; TUMOR CELLS, CULTURED;

EID: 33745409584     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.10.005     Document Type: Article

References (22)

1. Al-Mehdi A.B., Tozawa K., Fisher A.B., Shientag L., Lee A., and Muschel R.J. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 6 (2000) 100-102
2. Brezicka F., Einbeigi Z., and Bergman B. Functional assessment in vitro of human-complement-dependent antibody-induced cytotoxicity of neoplastic cells. Cancer Immunol. Immunother. 49 (2000) 235-242
3. Cameron M.D., Schmidt E.E., Kerkvliet N., Nadkarni K.V., Morris N.V., Groom A.C., Chambers A.F., and MacDonald I.C. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. 60 (2000) 2541-2546
4. Chan S.Y., and Pollard M. In vitro effects of lipoprotein-associated cytotoxic factor on rat prostate adenocarcinoma cells. Cancer Res. 38 (1978) 2956-2961
5. Chan S.Y., and Pollard M. Characterization of a very-low-density lipoprotein (VLDL)-associated cytotoxic factor. Br. J. Cancer 44 (1981) 410-417
6. Gelehrter T.D. Glucocorticoids and the plasma membrane. Monogr. Endocrinol. 12 (1979) 561-574
7. Glaves D. Correlation between circulating cancer cells and incidence of metastases. Br. J. Cancer 48 (1983) 665-673
8. Herr I., Ucur E., Herzer K., Okouoyo S., Ridder R., Krammer P.H., von Knebel Doeberitz M., and Debatin K.M. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res. 63 (2003) 3112-3120
9. Kinjo M. Lodgment and extravasation of tumour cells in blood-borne metastasis: an electron microscopic study. Br. J. Cancer 38 (1978) 293-301
10. Kodama M., and Kodama T. Enhanced effect of hydrocortisone on hematogenous metastasis of Ehrlich ascites tumor in mice. Cancer Res. 35 (1975) 1015-1021
11. Liszewski M.K., Post T.W., and Atkinson J.P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9 (1991) 431-455
12. Lublin D.M., and Atkinson J.P. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7 (1989) 35-58
13. Luzzi K.J., MacDonald I.C., Schmidt E.E., Kerkvliet N., Morris V.L., Chambers A.F., and Groom A.C. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153 (1998) 865-873
14. Markhus C.E., and Wiig H. Isolation of interstitial fluid from skeletal muscle and subcutis in mice using a wick method. Am. J. Physiol.: Heart Circ. Physiol. 287 (2004) 2085-2090
15. McDonald R.A., and Gelehrter T.D. Glucocorticoid regulation of amino acid transport in anucleate rat hepatoma (HTC) cells. J. Cell Biol. 88 (1981) 536-542
16. Shen W.H., Zhou J.H., Broussard S.R., Freund G.G., Dantzer R., and Kelley K.W. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. Cancer Res. 62 (2002) 4746-4756
17. Thaw H.H., Lukinius A., Brunk U.T., and Collins V.P. An approach to the assessment of membrane stability of cultured cells. Eur. J. Cell Biol. 29 (1983) 236-243
18. Weiss L. Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency. Int. J. Cancer 25 (1980) 385-392
19. Weiss L., Dimitrov D.S., and Angelova M. The hemodynamic destruction of intravascular cancer cells in relation to myocardial metastasis. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 5737-5741
20. Wong C.W., Lee A., Shientag L., Yu J., Dong Y., Kao G., Al-Mehdi A.B., Bernhard E.J., and Muschel R.J. Apoptosis: an early event in metastatic inefficiency. Cancer Res. 61 (2001) 333-338
21. Wong C.W., Song C., Grimes M.M., Fu W., Dewhirst M.W., Muschel R.J., and Al-Mehdi A.B. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am. J. Pathol. 161 (2002) 749-753
22. Yu B., Li S.Y., An P., Zhang Y.N., Liang Z.J., Yuan S.J., and Cai H.Y. Comparative study of proteome between primary cancer and hepatic metastatic tumor in colorectal cancer. World J. Gastroenterol. 10 (2004) 2652-2656